SEC Form 4 · accession 0001185185-18-000959
U.S. Stem Cell, Inc. · USRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mike Tomas
Officer — CEO & President · Director
Period of report
May 7, 2018
Accepted (ET)
May 18, 2018 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388319
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 9,793 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.0536 | May 7, 2018 | A | 20,000,000 | A | — | May 7, 2028 | Common Stock | 20,000,000 | 58,541,284 | D |
Explanation of responses
- F15,000,000 vest on 05/07/2019, 5,000,000 vest on 05/07/2020, 5,000,000 vest on 05/07/2021, and 5,000,000 vest on 05/07/2022.